Hearing on Venture Capital in Biotech

Only in Washington would an agriculture committee (okay, the Rural Enterprises, Agriculture and Technology Subcommittee of the House Small Business Committee) be holding a hearing on the role of venture capital in biotechnology. There are some interesting folks presenting, and one topic that will surely come up is the SBA’s recent bizarre decision that startups that are 51% (or more) owned by venture capital firms are ineligible for SBIR grants. Ouch.

According to a spokesthingie at the committee, however, the event will neither be televised on C-SPAN nor will it be webcast on the House Small Business website. Too bad, but there will apparently be transcripts up after the event.

Related posts:

  1. Pouring, Drinking, and the Allocation to Venture Capital
  2. Putting Venture Capital in Context
  3. Venture capital continues the slide
  4. Pining for the Glory Days of Venture Capital
  5. Speaking of Venture Capital and Innovation …